3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
38
Neoplasms
33
Depression
28
Fatigue
24
Prostatic Neoplasms
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Follicular
17
Multiple Myeloma
15
Lymphoma, Non-Hodgkin
14
Lymphoma, Mantle-Cell
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Burkitt Lymphoma
14
Lymphoma, B-Cell, Marginal Zone
13
Leukemia, Myeloid, Acute
13
Hodgkin Disease
13
Colorectal Neoplasms
13
Lymphoma, Large-Cell, Immunoblastic
12
Lung Neoplasms
12
Anxiety Disorders
12
Lymphoma
11
Leukemia, Myeloid, Chronic-Phase
11
Blast Crisis
11
Leukemia, Myeloid, Accelerated Phase
10
Recurrence
9
Pain
9
Lymphoma, T-Cell, Cutaneous
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Leukemia, Hairy Cell
9
Leukemia
9
Interventions
Hyperthermic Intraperitoneal Chemotherapy
27
Cisplatin
17
Oxaliplatin
16
Cytoreduction Surgical Procedures
15
Paclitaxel
12
Fluorouracil
10
Mitomycin
8
Leucovorin
8
Doxorubicin
7
Docetaxel
5
Neoadjuvant Therapy
4
Blood Specimen Collection
4
Taxes
3
Surgical Procedures, Operative
3
Chemotherapy, Adjuvant
3
Carboplatin
3
Bevacizumab
3
catumaxomab
2
Platinum
2
Palliative Care
2
Observation
2
Nivolumab
2
Mitozytrex
2
Laparoscopy
2
Interviews as Topic
2
Indocyanine Green
2
Folfox protocol
2
Albumin-Bound Paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
tremelimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Peritoneal Neoplasms
×
Therapeutics
×
Clear all
NCT02840331
2017-10-27
Hypericin-PDT
University Hospital Tuebingen
Phase 3
Unknown
50 enrolled